US2014128854A1PendingUtilityA1
Apparatus and processes for preventing or delaying one or more symptoms of presbyopia
Individually held — no corporate assignee on recordPriority: Nov 2, 2004Filed: Jan 14, 2014Published: May 8, 2014
Est. expiryNov 2, 2024(expired)· nominal 20-yr term from priority
A61F 9/00804A61F 2009/0087A61F 9/008A61F 2009/00895A61F 2009/00844A61F 2009/00897A61F 9/00825A61F 9/00817
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention generally relates to an apparatus and processes for preventing or delaying presbyopia. More particularly, the present invention relates to processes and apparatus for ablating epithelial cells in the germinative zone or the pregerminative zone of the crystalline lens of the eye so that onset or progression of presbyopia or one or more symptoms is delayed or prevented.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A process for preventing or delaying presbyopia by ablating epithelial cells in a crystalline lens, the process comprising the step of ablating epithelial cells in the germinative zone or the pregerminative zone of the crystalline lens, wherein the epithelial cells are ablated symmetrically.
2 . The process of claim 1 , wherein ablation points are made in the germinative zone of the crystalline lens.
3 . The process of claim 1 , wherein ablation points are made in the pregerminative zone of the crystalline lens.
4 . The process of claim 1 , wherein the epithelial cells are ablated along suture lines of the crystalline lens.
5 . The process of claim 1 , wherein an even number of ablation points are made around the crystalline lens.
6 . The process of claim 1 , wherein the crystalline lens has a circumference, and the process comprises making ablation points symmetrically around essentially the entire circumference.
7 . The process of claim 1 , wherein at least about 10% of the epithelial cells in the germinative zone of the crystalline lens are ablated.
8 . The process of claim 1 , wherein the epithelial cells are ablated without decreasing the equatorial diameter of the crystalline lens.
9 . The process of claim 1 , wherein the epithelial cells are ablated without forming a cataract or an astigmatic condition.
10 . A process for preventing or delaying one or more symptoms of presbyopia in a patient, the process comprising the steps of:
selecting a patient prior to detecting a symptom of presbyopia in the patient, and ablating epithelial cells in the germinative zone or the pregerminative zone of the crystalline lens.
11 . The process of claim 10 , wherein the patient is selected based on an increased risk factor for presbyopia.
12 . The process of claim 10 , wherein the patient is selected based on age.
13 . An apparatus for ablating epithelial cells in a crystalline lens, the apparatus comprising:
a laser source providing laser light radiation; and a laser delivery system operatively connected to the laser source for receiving the radiation from the laser source and generating a plurality of laser beams.
14 . The apparatus of claim 13 , wherein the laser provides radiation having a wavelength in the range of about 400 nm to about 1400 nm.
15 . The apparatus of claim 13 , wherein the laser delivery system comprises a fiber optic bundle.
16 . The apparatus of claim 13 , wherein the laser delivery system comprises a diffractive optic or a binary optic.
17 . The apparatus of claim 13 , wherein the laser delivery system comprises a focus lens for receiving and focusing the plurality of laser beams.
18 . The apparatus of claim 17 , wherein the laser delivery system comprises a plurality of focus lenses having different focal lengths.
19 . The apparatus of claim 13 , wherein the laser delivery system comprises a rotator for automatically rotating the plurality of laser beams.
20 . The apparatus of claim 13 , wherein the laser apparatus comprises an alignment mechanism which provides visible light at the ablation points.Join the waitlist — get patent alerts
Track US2014128854A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.